The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mann, M. K.
Right arrow Articles by Dittel, B. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mann, M. K.
Right arrow Articles by Dittel, B. N.
The Journal of Immunology, 2007, 178: 3447-3456.
Copyright © 2007 by The American Association of Immunologists, Inc.

B Cell Regulation of CD4+CD25+ T Regulatory Cells and IL-10 Via B7 is Essential for Recovery From Experimental Autoimmune Encephalomyelitis1

Monica K. Mann*,{dagger}, Katarzyna Maresz*, Leah P. Shriver*,{dagger}, Yanping Tan* and Bonnie N. Dittel2,*,{dagger}

* BloodCenter of Wisconsin, Blood Research Institute, Milwaukee, WI 53226; and {dagger} Department of Microbiology and Molecular Genetics, Medical College of Wisconsin, Milwaukee, WI 53226

CD4+CD25+ T regulatory (Treg) cells expressing the Foxp3 transcription factor have been shown to be present in the CNS during the autoimmune disease experimental autoimmune encephalomyelitis (EAE) and can inhibit EAE clinical disease by an IL-10-dependent mechanism. In addition, IL-10 expression in the CNS late in the EAE disease course has been attributed to recovery. However, it is not known how Treg cells and IL-10 expressions are regulated during EAE. We have previously shown a requirement for B cells in recovery from EAE and here investigated whether this was due to a deficiency in Treg cells and IL-10 in the CNS. We found that B cell deficiency resulted in a delay in the emergence of Foxp3-expressing Treg cells and IL-10 in the CNS during EAE, but not in the periphery. Reconstitution with wild-type B cells resulted in disease recovery and normalized IL-10 and Foxp3 expression. However, reconstitution with B7-deficient B cells did not. Furthermore, we show that IL-10 and Foxp3 expression is enhanced in CNS nonencephalitogenic T cells. These data suggest a novel mechanism whereby B cells regulate CD4+CD25+ Treg cells via B7 and subsequently enter the CNS and suppress autoimmune inflammation, mediating recovery.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported in part by National Multiple Sclerosis Society Grants RG 3299-A-2 and PP0778 and the BloodCenter Research Foundation.

2 Address correspondence and reprint requests to Dr. Bonnie N. Dittel, P.O. Box 2178, 8727 Watertown Plank Road, Milwaukee, WI 53201. E-mail address: bonnie.dittel{at}bcw.edu

3 Abbreviations used in this paper: MS, multiple sclerosis; BM, bone marrow; EAE, experimental autoimmune encephalomyelitis; MBP, myelin basic protein; SA, streptavidin; Treg, T regulatory; WT, wild type.




This article has been cited by other articles:


Home page
JEMHome page
B. Pollinger, G. Krishnamoorthy, K. Berer, H. Lassmann, M. R. Bosl, R. Dunn, H. S. Domingues, A. Holz, F. C. Kurschus, and H. Wekerle
Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells
J. Exp. Med., June 8, 2009; 206(6): 1303 - 1316.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Lee, E. K. Reinke, A. L. Zozulya, M. Sandor, and Z. Fabry
Mycobacterium bovis Bacille Calmette-Guerin Infection in the CNS Suppresses Experimental Autoimmune Encephalomyelitis and Th17 Responses in an IFN-{gamma}-Independent Manner
J. Immunol., November 1, 2008; 181(9): 6201 - 6212.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Li, G.-X. Zhang, Y. Chen, H. Xu, D. C. Fitzgerald, Z. Zhao, and A. Rostami
CD11c+CD11b+ Dendritic Cells Play an Important Role in Intravenous Tolerance and the Suppression of Experimental Autoimmune Encephalomyelitis
J. Immunol., August 15, 2008; 181(4): 2483 - 2493.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Fehr, F. Haspot, J. Mollov, M. Chittenden, T. Hogan, and M. Sykes
Alloreactive CD8 T Cell Tolerance Requires Recipient B Cells, Dendritic Cells, and MHC Class II
J. Immunol., July 1, 2008; 181(1): 165 - 173.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Yu, R. Dunn, M. R. Kehry, and H. Braley-Mullen
B Cell Depletion Inhibits Spontaneous Autoimmune Thyroiditis in NOD.H-2h4 Mice
J. Immunol., June 1, 2008; 180(11): 7706 - 7713.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. W. Kin, D. M. Crawford, J. Liu, T. W. Behrens, and J. F. Kearney
DNA Microarray Gene Expression Profile of Marginal Zone versus Follicular B Cells and Idiotype Positive Marginal Zone B Cells before and after Immunization with Streptococcus pneumoniae
J. Immunol., May 15, 2008; 180(10): 6663 - 6674.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Lampropoulou, K. Hoehlig, T. Roch, P. Neves, E. C. Gomez, C. H. Sweenie, Y. Hao, A. A. Freitas, U. Steinhoff, S. M. Anderton, et al.
TLR-Activated B Cells Suppress T Cell-Mediated Autoimmunity
J. Immunol., April 1, 2008; 180(7): 4763 - 4773.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X. Chen and P. E. Jensen
Cutting Edge: Primary B Lymphocytes Preferentially Expand Allogeneic FoxP3+ CD4 T Cells
J. Immunol., August 15, 2007; 179(4): 2046 - 2050.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.